This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of nasal cavity and sinuses
C3_NASAL_CAVITY_SINUSES
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
280 |
4. Check minimum number of eventsNone |
280 |
5. Include endpointsNone |
280 |
6. Filter based on genotype QC (FinnGen only) |
249 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasal cavity and sinuses
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasal cavity and sinuses, including Hilmo
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 249 | 97 | 152 |
| Unadjusted period prevalence (%) | 0.06 | 0.03 | 0.07 |
| Median age at first event (years) | 65.22 | 64.20 | 65.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 261
- Matched controls
- 2610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
164.5
140
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
20.6
114.5
103
80
130
Kela drug reimbursment
Malignant tumour
+∞
106.8
95
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
82.8
75
*
XX3DW
NOMESCO Finland
Time consuming IT work
17.4
81.3
75
59
WF002
NOMESCO Finland
Radical radiotherapy
1003.1
78.6
73
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
127.1
77.2
80
9
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
157.7
76.9
78
7
A04AA01
ATC
ondansetron; systemic, rectal
27.6
76.7
55
25
H02AB02
ATC
dexamethasone; systemic
118.2
72.6
76
9
UDM02
NOMESCO Finland
Sinoscopy
31.6
69.5
47
18
A03FA01
ATC
metoclopramide; systemic, rectal
9.1
65.1
106
182
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.8
64.5
47
22
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
338.6
55.5
54
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
24.1
55.1
41
20
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
54.1
50
*
WZC00
NOMESCO Finland
Treatment plan or consultation
6.8
54.0
146
411
DHB10
NOMESCO Finland
Excision of lesion of internal nose
307.6
51.0
50
*
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
50.7
47
*
A04AA02
ATC
granisetron; systemic, transdermal
551.4
47.9
46
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
15.4
47.2
44
34
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
46.2
43
*
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
45.1
42
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
263.3
44.4
44
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.7
44.1
44
38
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
44.0
41
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
44.0
41
*
Z51.5
ICD-10 Finland
Palliative care
11.4
43.9
50
53
N02AA05
ATC
oxycodone; systemic
6.4
43.8
98
225
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
11.1
41.4
48
52
R04.0
ICD-10 Finland
Epistaxis
7.7
38.6
63
104
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
384.6
34.8
34
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
129.7
32.5
34
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
30.8
29
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.3
30.7
34
34
JN4BD
NOMESCO Finland
Extensive body CT
9.0
30.7
41
53
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
94.1
30.5
33
*
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
339.6
30.5
30
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
121.0
30.4
32
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
12.4
29.0
30
27
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
28.7
27
*
L03AA02
ATC
filgrastim; parenteral
313.3
28.3
28
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
27.6
26
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.6
27.3
34
40
ZX090
NOMESCO Finland
Other technic of radiotherapy
108.3
27.3
29
*
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
26.5
25
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
26.5
25
*
WX402
NOMESCO Finland
General anaesthesia
4.4
25.8
86
264
WF049
NOMESCO Finland
Radiotherapy of metastasis
275.3
25.1
25
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
24.3
23
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
24.3
23
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.3
23.8
44
81
DPA30
NOMESCO Finland
Sphenotomy
40.5
23.5
29
8
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
23.3
22
*
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
23.3
22
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
49.9
22.8
27
6
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
22.2
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
22.0
94
339
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.0
21.6
42
81
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.9
21.5
54
131
A07AA02
ATC
nystatin; oral
6.5
21.4
38
67
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
21.1
20
*
DHB40
NOMESCO Finland
Conchotomy
119.6
20.9
22
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
+∞
20.1
19
*
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
+∞
20.1
19
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
20.1
19
*
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
20.1
19
*
L03AA13
ATC
pegfilgrastim; parenteral
113.7
19.9
21
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.2
19.6
131
618
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
19.0
18
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
56.8
18.2
21
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
71.8
18.0
20
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
17.9
17
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
17.9
17
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
17.9
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.9
17
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
17.9
17
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
192.5
17.7
18
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
7.0
17.5
28
44
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.0
17.4
133
666
ZZR00
NOMESCO Finland
Flap of skin
+∞
16.8
16
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
16.8
16
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
16.8
16
*
WZC30
NOMESCO Finland
Teaching
3.9
16.6
57
174
J33.0
ICD-10 Finland
Polyp of nasal cavity
7.1
16.5
26
40
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.7
15.8
58
185
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
15.8
15
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
15.8
15
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.8
15
*
ZX120
NOMESCO Finland
Intravenous
5.4
15.2
32
66
ZXE20
NOMESCO Finland
More than three and less than five hours
3.7
15.0
55
175
JN4AD
NOMESCO Finland
Body CT examination
5.1
15.0
34
75
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
85.0
14.7
16
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
14.7
14
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
+∞
14.7
14
*
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
14.7
14
*
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
+∞
14.7
14
*
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
14.7
14
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
158.5
14.6
15
*
XW000
NOMESCO Finland
Bone marrow biopsy
13.0
14.4
25
21
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.6
14.2
36
87
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
11.4
14.1
26
25
AA1BD
NOMESCO Finland
Extensive CT of head and brain
18.9
14.1
21
12
ZXE40
NOMESCO Finland
More than seven and less than nine hours
25.5
14.0
19
8
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
56.5
14.0
16
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
13.7
13
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
13.7
13
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
13.7
13
*
L01CB01
ATC
etoposide; systemic
+∞
13.7
13
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.5
13.6
24
21
ZXC95
NOMESCO Finland
Use of surgical navigator
19.6
13.6
20
11
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
147.3
13.6
14
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
13.3
70
278
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
13.2
47
146
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
13.1
47
147
EBA10
NOMESCO Finland
Operative extraction of tooth
3.9
13.0
42
122
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
52.8
13.0
15
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
6.1
12.7
23
41
A04AD12
ATC
aprepitant; systemic
+∞
12.6
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
12.6
12
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
12.6
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.6
12
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
12.6
12
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
12.6
12
*
SAA04
NOMESCO Finland
Special examination of mouth
5.8
12.5
24
45
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.3
12.4
26
53
SBB10
NOMESCO Finland
Dental impressions
4.9
12.2
28
62
WW500
NOMESCO Finland
Blood transfusion
11.3
12.0
22
21
ZXA05
NOMESCO Finland
Left side
2.7
11.6
86
407
A79
ICPC
Malignancy NOS
+∞
11.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
11.5
11
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
125.3
11.5
12
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
125.3
11.5
12
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
125.3
11.5
12
*
ZZC00
NOMESCO Finland
Graft of fascia
125.3
11.5
12
*
GD6AD
NOMESCO Finland
CT of chest and neck
36.8
11.4
14
*
EBB10
NOMESCO Finland
Insertion of dental implant
21.2
11.3
16
8
R4190
NOMESCO Finland
Nutritional therapy
10.3
11.0
21
22
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
29.4
10.8
14
5
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
22.6
10.8
15
7
DKW40
NOMESCO Finland
Ligature of artery of internal nose
114.4
10.5
11
*
DPB00
NOMESCO Finland
Partial excision of frontal sinus
114.4
10.5
11
*
DHB01
NOMESCO Finland
Partial excision of external nose
+∞
10.5
10
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
+∞
10.5
10
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
10.5
10
*
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
+∞
10.5
10
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
10.5
10
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
10.5
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
10.5
10
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
11.3
10.5
19
18
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
10.2
10.5
20
21
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
34.0
10.4
13
*
J33.9
ICD-10 Finland
Nasal polyp, unspecified
19.8
10.4
15
8
GD1AD
NOMESCO Finland
Thorax CT examination
4.2
10.3
29
76
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.7
10.0
33
97
JN6AD
NOMESCO Finland
CT of torso and neck
21.0
9.9
14
7
GBB00
NOMESCO Finland
Tracheostomy
27.2
9.9
13
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
9.8
53
211
WX110
NOMESCO Finland
Infiltration anesthesia
2.4
9.7
184
1297
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
103.6
9.5
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
9.4
9
*
ZZR50
NOMESCO Finland
Mucoperiosteal flap
+∞
9.4
9
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
9.4
9
*
DLW99
NOMESCO Finland
Other plastic operations on nose
+∞
9.4
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.4
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
9.4
9
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
9.4
9
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
9.4
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
9.3
100
553
ZXE00
NOMESCO Finland
One hour or less
2.3
9.2
105
594
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
9.6
9.2
18
20
J01MA12
ATC
levofloxacin; systemic
2.6
9.0
60
266
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.0
8.7
19
40
DHB00
NOMESCO Finland
Excision of lesion of external nose
92.9
8.5
9
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
92.9
8.5
9
*
WX002
NOMESCO Finland
Sedation and analgesia
2.5
8.4
60
274
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
11.3
8.4
15
14
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
+∞
8.4
8
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
8.4
8
*
8072/3-C30.0
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasal cavity
+∞
8.4
8
*
8020/3-C30.0
ICD-O-3
Carcinoma, undifferentiated, NOS, of nasal cavity
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
+∞
8.4
8
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.4
8.3
69
339
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
8.2
104
609
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.2
8.2
14
12
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
22.9
8.1
11
5
SPF20
NOMESCO Finland
Temporary relining of dentures
22.9
8.1
11
5
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
4.7
8.0
19
43
ZZA00
NOMESCO Finland
Split skin graft
8.2
8.0
17
22
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
11.3
7.9
14
13
R01AD09
ATC
mometasone; nasal
2.1
7.9
120
752
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
7.8
120
754
JN4CD
NOMESCO Finland
Very extensive body CT
15.6
7.8
12
8
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
15.6
7.8
12
8
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
8.4
7.7
16
20
SCA02
NOMESCO Finland
Preventive oral health care
3.2
7.6
31
104
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
7.6
137
909
H65.2
ICD-10 Finland
Chronic serous otitis media
10.5
7.6
14
14
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
25.9
7.6
10
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
25.9
7.6
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
7.5
64
317
UDC00
NOMESCO Finland
Ear microscopy
3.1
7.5
32
111
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
13.9
7.5
12
9
L02AE02
ATC
leuprorelin; implant, parenteral
82.3
7.5
8
*
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
82.3
7.5
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.2
7.2
80
442
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
41.2
6.8
8
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
41.2
6.8
8
*
K11.70
ICD-10 Finland
Hypoptyalism
41.2
6.8
8
*
H16.0
ICD-10 Finland
Corneal ulcer
3.7
6.7
22
64
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.6
6.6
18
34
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
4.1
6.6
18
46
WX872
NOMESCO Finland
Intensive care
3.4
6.5
24
76
DKW10
NOMESCO Finland
Packing of anterior cavity of nose
71.5
6.5
7
*
ZZA50
NOMESCO Finland
Full thickness skin graft
71.5
6.5
7
*
ZXC86
NOMESCO Finland
Use of endoscopic device
71.5
6.5
7
*
R06
ICPC
Nose bleed/epistaxis
6.8
6.4
15
23
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
6.2
6.4
16
27
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.4
6.4
11
10
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
18.6
6.3
9
5
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
18.6
6.3
9
5
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
6.3
6
*
DCB00
NOMESCO Finland
Excision of lesion of middle ear
+∞
6.3
6
*
EEB20
NOMESCO Finland
Hemimaxillectomy
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
8720/3-C31.0
ICD-O-3
Malignant melanoma, NOS, of maxillary sinus
+∞
6.3
6
*
8200/3-C30.0
ICD-O-3
Adenoid cystic carcinoma of nasal cavity
+∞
6.3
6
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
H02AB06
ATC
prednisolone; systemic
1.9
6.3
128
870
A06AH03
ATC
naloxegol; oral
27.4
6.3
8
*
TAB00
NOMESCO Finland
Lumbar puncture
3.8
6.2
19
53
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
6.2
48
227
XX2RW, ,
NOMESCO Finland
12.9
6.1
10
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.1
129
885
A02BC02
ATC
pantoprazole; systemic
2.0
6.0
177
1349
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
181
1033
3.45
19.51
8.4
6.1
1.21
1.21
mmol/l
0.05
154
903
166
907
3.28
19.12
7.3
5.8
1.20
1.21
mmol/l
0.19
159
830
161
879
3.17
18.29
4.1
2.4
—
—
estimate
—
0
0
184
1089
3.34
18.08
17.5
6.3
3.93
4.32
e9/l
1.61
163
949
30
51
6.52
17.40
2.4
2.5
1.08
1.65
mg/l
4.09
30
42
23
17
14.71
14.02
1.2
1.1
—
—
—
0
0
20
12
17.92
13.21
1.5
1.3
18.61
22.63
ng/l
0.42
20
12
23
22
11.35
12.53
1.3
1.2
288.04
261.73
mosm/kgh2o
1.90
23
15
126
699
2.55
12.36
5.6
2.0
2.37
2.35
mmol/l
1.23
121
606
94
457
2.65
12.08
2.8
2.0
—
—
—
0
0
24
47
5.52
11.98
1.4
1.5
—
—
—
0
0
61
264
2.71
9.65
7.4
7.2
0.88
1.07
mmol/l
0.13
48
227
26
69
4.07
9.03
1.8
4.2
—
—
—
0
0
38
140
3.01
8.02
1.3
1.5
—
—
—
0
0
19
44
4.58
7.82
1.8
1.5
—
—
—
0
0
15
17
9.29
7.65
1.3
1.2
—
—
—
0
0
12
12
10.42
6.60
2.3
4.7
—
—
—
0
0
48
221
2.44
6.55
3.7
1.9
7.60
6.79
umol/l
0.10
42
192
16
27
6.24
6.41
1.3
1.3
—
—
—
0
0
18
49
3.87
6.03
1.9
2.7
4.20
3.96
g/l
0.17
18
49
28
103
2.92
5.91
3.6
1.5
3.80
2.53
ug/l
0.51
21
78
61
326
2.14
5.83
6.3
6.0
103.97
104.46
mmol/l
0.31
61
326
90
569
1.89
5.31
2.9
3.1
0.27
0.43
e6/l
0.77
66
409
38
173
2.40
5.29
3.9
1.8
75.65
67.00
ml/min/173m2
0.72
20
68
9
10
9.27
4.82
2.1
1.1
—
—
—
0
0
9
11
8.43
4.60
1.7
1.9
16.78
11.91
%
—
9
11
41
205
2.19
4.59
5.5
3.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
55
3.24
4.45
3.4
2.2
0.26
0.40
iu/ml
0.95
12
28
48
259
2.05
4.41
2.7
1.8
—
—
—
0
0
16
50
3.34
4.41
2.2
2.3
84.06
90.50
%
0.46
16
50
15
38
4.12
4.37
1.9
1.2
—
—
—
0
0
8
9
9.12
4.31
1.6
2.4
—
—
—
0
0
32
148
2.32
4.30
8.9
8.9
0.63
0.68
%
0.33
32
148
7
6
11.94
4.30
2.9
1.8
4.17
6.13
nmol/l
—
7
6
172
2017
0.57
4.28
4.5
5.4
1.39
1.42
mmol/l
0.43
160
1865
15
39
4.02
4.27
2.4
1.5
—
—
—
0
0
14
41
3.55
4.25
1.4
1.4
—
—
—
0
0
50
280
1.97
4.14
2.7
1.7
—
—
—
0
0
14
42
3.47
4.10
2.6
1.5
—
—
—
0
0
174
2026
0.58
4.04
4.5
5.5
4.61
4.49
mmol/l
0.73
162
1883
15
51
3.06
3.64
1.5
1.2
—
—
—
0
0
55
842
0.56
3.58
4.7
4.2
5.85
7.58
mg/mmol
0.19
35
550
11
26
4.37
3.55
1.6
1.3
—
—
—
0
0
12
31
4.01
3.54
1.7
1.3
—
—
—
0
0
180
2059
0.59
3.52
5.0
6.3
2.66
2.60
mmol/l
0.30
165
1904
12
34
3.65
3.24
2.0
1.2
—
—
—
0
0
10
24
4.29
3.23
2.2
1.5
—
—
—
0
0
57
360
1.75
3.21
2.9
1.8
—
—
—
0
0
13
45
2.99
3.07
1.9
1.6
—
—
—
0
0
17
69
2.57
3.02
5.7
1.2
77.77
32.48
mg/l
0.73
17
62
168
1926
0.64
2.85
4.0
4.6
1.38
1.30
mmol/l
0.68
151
1765
9
23
4.01
2.80
1.0
1.1
—
—
—
0
0
67
459
1.62
2.77
3.5
4.3
205.21
381.39
ng/l
0.51
57
373
65
905
0.62
2.73
1.7
2.0
1.38
1.35
mmol/l
0.13
56
757
10
29
3.54
2.72
2.9
1.6
—
—
—
0
0
222
2000
1.74
2.61
29.4
14.4
29.04
24.27
mg/l
1.06
203
1589
5
7
7.25
2.56
2.2
6.9
—
—
—
0
0
16
69
2.40
2.54
6.0
1.2
25.69
46.15
mg/l
2.00
16
62
8
21
3.89
2.48
1.8
1.3
—
—
—
0
0
6
12
5.09
2.41
1.0
1.0
—
—
—
0
0
6
12
5.09
2.41
2.5
1.8
0.80
1.06
e9/l
—
6
12
154
1295
1.46
2.33
4.2
4.5
902.00
243.76
e6/l
—
7
17
12
47
2.63
2.30
2.3
2.6
219.00
182.91
%
0.69
12
47
32
188
1.80
2.30
3.2
2.0
23.33
30.93
u/l
2.87
27
152
7
18
3.96
2.26
2.7
1.9
—
—
—
0
0
7
20
3.57
2.07
2.9
1.7
—
—
—
0
0
7
21
3.40
1.98
1.9
1.5
—
—
—
0
0
7
21
3.40
1.98
2.9
1.5
—
—
—
0
0
8
185
0.41
1.89
2.9
2.2
3.24
3.56
ratio
—
8
161
28
440
0.59
1.87
1.1
1.4
5.50
1.49
u/ml
—
9
121
6
17
3.59
1.85
1.2
1.1
—
—
—
0
0
6
17
3.59
1.85
1.2
1.1
—
—
—
0
0
6
17
3.59
1.85
1.2
1.1
—
—
—
0
0
15
73
2.12
1.84
5.5
1.2
10.77
10.06
g/l
0.26
15
62
74
564
1.44
1.81
4.2
2.4
331.88
362.62
umol/l
2.24
69
490
6
19
3.21
1.67
1.2
1.1
—
—
—
0
0
6
19
3.21
1.67
1.2
1.1
—
—
—
0
0
6
19
3.21
1.67
1.2
1.1
—
—
—
0
0
74
574
1.40
1.63
2.0
2.2
2.83
2.76
mg/l
0.15
64
490
26
160
1.69
1.63
4.4
1.8
66.12
66.93
g/l
0.26
26
147
183
1999
0.72
1.62
4.9
5.4
6.05
6.06
mmol/l
0.06
170
1817
25
390
0.60
1.62
1.2
1.3
24.83
34.80
iu/ml
—
6
120
6
20
3.05
1.59
1.2
1.2
—
—
—
0
0
7
27
2.64
1.52
1.4
1.2
—
—
—
0
0
182
1638
1.37
1.51
34.0
17.7
14.33
13.62
%
7.53
182
1613
38
531
0.67
1.51
2.9
2.7
0.74
0.71
ug/l
0.08
28
336
6
23
2.65
1.37
3.7
3.0
—
—
—
0
0
21
129
1.68
1.34
2.5
1.6
—
—
—
0
0
86
710
1.32
1.25
2.3
2.1
203.36
300.85
u/l
0.41
81
664
183
1974
0.76
1.23
5.7
7.2
40.08
40.08
mmol/mol
0.00
169
1844
5
19
2.66
1.22
2.2
1.6
—
—
—
0
0
207
1928
1.36
1.19
27.3
14.0
81.61
77.65
ml/min/173m2
2.39
197
1780
21
134
1.62
1.18
1.1
1.3
27.17
116.49
u/ml
—
6
51
0
35
0.00
1.16
0.0
1.4
—
932.45
—
0
30
17
265
0.62
1.12
4.4
5.3
31.20
31.61
%
—
10
165
88
1031
0.78
1.11
2.2
2.1
89.98
94.17
pmol/l
0.35
49
533
15
89
1.73
1.10
5.5
1.3
3.45
3.71
g/l
0.34
15
78
15
89
1.73
1.10
5.5
1.3
4.22
4.31
g/l
0.17
15
78
15
89
1.73
1.10
5.5
1.3
6.34
7.61
g/l
4.07
15
78
44
336
1.37
1.06
2.9
3.0
0.65
2.44
e6/l
2.13
22
158
12
68
1.80
1.02
6.6
1.3
0.48
0.00
g/l
0.47
12
62
168
1537
1.26
1.01
5.2
4.0
14.37
14.85
pmol/l
1.69
161
1402
170
1558
1.26
1.00
5.2
4.3
17.40
12.19
mm/h
3.52
164
1438
14
85
1.68
0.96
5.9
1.3
2.87
2.98
g/l
0.13
14
74
9
51
1.79
0.95
1.1
1.2
—
—
—
0
0
18
119
1.55
0.91
2.3
1.5
—
—
—
0
0
57
467
1.28
0.87
1.6
1.7
2.39
0.99
mg/l
1.31
47
360
0
28
0.00
0.76
0.0
1.1
—
1.04
—
0
6
45
364
1.29
0.76
2.7
2.8
0.84
1.09
e6/l
0.34
22
189
8
135
0.58
0.75
2.1
2.0
3.04
3.57
mmol/l
—
8
111
33
256
1.33
0.75
2.6
3.0
5.95
5.77
kpa
0.59
33
249
25
187
1.37
0.71
2.4
2.4
0.52
0.34
e6/l
0.36
25
175
5
26
1.94
0.71
1.2
1.2
150.80
132.18
u/ml
—
5
11
12
77
1.59
0.70
6.9
1.2
0.93
0.33
g/l
0.47
12
67
5
91
0.54
0.68
1.0
1.3
—
—
—
0
0
32
256
1.28
0.60
2.6
2.9
2.99
1.83
mmol/l
1.86
32
213
6
35
1.73
0.58
2.5
1.5
—
—
—
0
0
6
35
1.73
0.58
2.5
1.5
—
—
—
0
0
17
125
1.39
0.55
2.6
3.5
3.76
1.95
mmol/l
0.76
11
86
9
62
1.47
0.53
1.4
1.2
—
—
—
0
0
197
1890
1.17
0.49
5.7
5.1
2.18
1.98
mu/l
0.93
184
1717
69
770
0.86
0.48
4.5
3.7
23.99
24.58
%
0.09
36
338
85
775
1.14
0.43
3.0
3.1
1278.33
1359.79
ng/l
0.05
77
655
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
3.2
—
16.33
—
0
15
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.41
0.0
1.4
—
1.47
—
0
11
0
17
0.00
0.41
0.0
1.4
—
1.16
—
0
11
0
17
0.00
0.41
0.0
1.4
—
1.11
—
0
11
5
34
1.48
0.40
2.2
2.9
4.16
10.12
pmol/l
—
5
34
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
73
668
1.13
0.35
2.0
1.7
18.83
20.25
nmol/l
0.32
64
560
140
1331
1.11
0.34
3.6
3.3
52.62
49.98
u/l
0.17
134
1251
118
1114
1.11
0.33
2.8
2.7
—
—
—
0
0
224
2192
1.15
0.31
40.1
22.0
244.26
242.36
e9/l
0.15
218
2143
10
75
1.35
0.30
2.3
1.5
—
—
—
0
0
224
2193
1.15
0.30
40.1
21.9
4.21
4.53
e12/l
12.74
218
2136
65
597
1.12
0.30
4.2
3.2
0.00
0.00
estimate
-0.00
25
168
96
902
1.10
0.29
2.3
2.5
76.42
77.14
nmol/l
0.10
89
803
6
84
0.71
0.24
1.8
2.2
236.83
218.87
pmol/l
—
6
77
65
606
1.10
0.23
4.2
3.8
0.00
0.00
estimate
-0.00
28
192
91
959
0.92
0.23
4.4
4.0
3.07
1.83
ug/l
0.54
84
849
10
79
1.28
0.22
3.3
1.6
—
—
—
0
0
45
413
1.11
0.21
1.4
1.7
1126.78
1167.26
nmol/l
0.12
35
313
0
10
0.00
0.21
0.0
1.1
—
40.43
—
0
10
0
12
0.00
0.21
0.0
1.3
—
16.33
—
0
6
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
48
518
0.91
0.20
2.8
4.0
1.02
1.02
kg/l
0.24
35
327
0
14
0.00
0.20
0.0
1.4
—
57.08
—
0
14
13
109
1.20
0.19
2.5
3.6
1.02
1.02
ratio
0.06
13
103
25
279
0.89
0.19
1.1
1.5
—
—
—
0
0
11
129
0.85
0.15
1.5
1.6
—
—
—
0
0
91
937
0.96
0.10
3.9
3.9
655.37
78.33
ng/l
0.45
71
698
19
206
0.92
0.09
1.4
1.5
—
—
—
0
0
5
61
0.82
0.08
1.2
1.6
—
—
—
0
0
5
60
0.83
0.08
1.4
1.5
—
0.07
—
0
14
5
60
0.83
0.08
1.2
1.9
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
0.93
0.89
g/l
—
5
63
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
7
64
1.10
0.08
1.1
1.2
—
—
—
0
0
8
95
0.84
0.07
1.1
1.0
—
—
—
0
0
111
1091
1.03
0.06
3.7
3.9
0.00
0.00
estimate
-0.00
29
210
13
141
0.92
0.05
1.8
2.3
0.86
1.20
%
1.87
13
141
109
1076
1.02
0.04
3.7
3.8
0.00
0.00
estimate
-0.00
29
209
16
168
0.95
0.02
1.7
1.4
—
—
—
0
0
27
263
1.03
0.01
12.2
7.8
—
—
—
0
0
13
136
0.95
0.00
1.8
2.3
0.52
0.61
%
0.96
13
136
13
128
1.02
0.00
2.3
2.7
26.08
24.86
mmol/l
0.95
13
123
13
131
0.99
0.00
1.3
1.2
172.63
522.80
u/ml
0.91
13
125
15
147
1.02
0.00
1.6
1.8
—
—
—
0
0
85
853
0.99
0.00
3.9
3.7
0.00
0.00
estimate
-0.00
22
171
94
945
0.99
0.00
2.3
3.0
168.63
126.55
ug/l
0.88
88
877
21
210
1.00
-0.00
2.3
2.6
4.38
4.41
kpa
0.03
21
201
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
-0.00
1.7
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
21.32
—
0
5
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
8.88
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
110
1100
1.00
-0.00
3.8
3.9
0.00
0.02
estimate
0.50
28
195
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
7.84
—
0
5
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NASAL_CAVITY_SINUSES – Malignant neoplasm of nasal cavity and sinuses
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).